Genetic variation of enzyme linked with outcomes for women receiving tamoxifen
Tuesday, October 6, 2009 - 15:49
in Health & Medicine
Among women with early stage breast cancer, genetic variation of a certain enzyme appears to be associated with clinical outcomes for women treated with tamoxifen, according to a study in the October 7 issue of JAMA.